Quinalbarbitone

Secobarbital sodium (marketed by Eli Lilly and Company for the treatment of insomnia, and subsequently by other companies as described below, under the brand name Seconal) is a short acting barbiturate derivative drug that was patented in 1934 in the United States. It possesses anaesthetic, anticonvulsant, anxiolytic, sedative, and hypnotic properties. In the United Kingdom, it was known as quinalbarbitone. It is the most frequently used drug in physician-assisted suicide within the United States. Although secobarbital is considered to be an obsolete sedative-hypnotic (sleeping pill), it has largely been replaced by the benzodiazepine family. Seconal was widely abused, known on the streets as 'red devils' or 'reds'. Secobarbital sodium (marketed by Eli Lilly and Company for the treatment of insomnia, and subsequently by other companies as described below, under the brand name Seconal) is a short acting barbiturate derivative drug that was patented in 1934 in the United States. It possesses anaesthetic, anticonvulsant, anxiolytic, sedative, and hypnotic properties. In the United Kingdom, it was known as quinalbarbitone. It is the most frequently used drug in physician-assisted suicide within the United States. Although secobarbital is considered to be an obsolete sedative-hypnotic (sleeping pill), it has largely been replaced by the benzodiazepine family. Seconal was widely abused, known on the streets as 'red devils' or 'reds'.